Tumor Necrosis Factor-α Blockade for Treatment of Acute Kawasaki Disease-Reference-Cited by-同舟云学术

Tumor Necrosis Factor-α Blockade for Treatment of Acute Kawasaki Disease

Published:2016-08-28 Issue: Volume: Page:169-173
ISSN:
Container-title:Kawasaki Disease
language:
Short-container-title:

Author:

Tremoulet Adriana H.

Publisher

Springer Japan

Link

http://link.springer.com/content/pdf/10.1007/978-4-431-56039-5_17

Reference19 articles.

1. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, et al. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol. 1988;48(2):247–51. http://dx.doi.org/10.1016/0090-1229(88)90088-8 PMID:3390972.

2. Matsubara T. Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions. Arerugi. 1990;39(2 Pt 1):118–23. PMID:2112909.

3. Burns JC, Capparelli EV, Brown JA, Newburger JW. Glode MP; US/Canadian Kawasaki Syndrome Study Group. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J. 1998;17(12):1144–8. http://dx.doi.org/10.1097/00006454-199812000-00009 PMID:9877364.

4. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr. 2008;153(1):117–21. http://dx.doi.org/10.1016/j.jpeds.2007.12.021 PMID:18571548.

5. Oharaseki T, Yokouchi Y, Yamada H, Mamada H, Muto S, Sadamoto K, et al. The role of TNF-alpha in a murine model of Kawasaki disease arteritis induced with a Candida albicans cell wall polysaccharide. Mod Rheumatol. 2014;24(1):120–8. http://dx.doi.org/10.3109/14397595.2013.854061 .